Humanigen (HGENQ) 10-Q2019 Q1 Quarterly report

Filed: 3 May 19, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: administered, aim, anniversary, antigen, ASU, beginning, biomarker, biopharmaceutical, Brisbane, bulk, buyer, care, ceased, chimeric, companion, compel, composition, consumed, document, downstream, earlier, efficient, efficiently, EGC, elevated, elevation, essential, evidence, expedient, experienced, facilitate, field, footnote, grantor, group, hamper, highly, hospital, impeded, inclusion, incremental, induced, lease, led, linking, LP, marketplace, Mayo, method, minimize, month, multitude, myeloid, neurologic, NT, ONJCI, onset, pace, package, partnership, perpetuating, practical, proliferation, prophylactic, prophylactically, Queensland, ration, reconciling, recruitment, recurrent, regimen, relapse, relapsed, represent, safer, science, serve, shown, signaling, simultaneously, site, smaller, Sound, standard, suffer, timeline, Topic, trafficking, transformation, transition, transitional, utility, vasculature, View

Removed: aberrantly, absent, addressing, advanced, afforded, agent, ameliorating, amend, animal, Aperture, applied, approach, approximated, area, Article, ASC, assign, assignment, authorize, Bay, bearing, began, begun, BHC, BHCMF, binding, bore, bridge, cancellation, capable, carve, Certificate, Charter, Codification, cohort, combined, compromise, Confirmation, confirming, consent, contemplated, credited, dated, decision, declared, decline, deemed, designated, Designation, detailed, discontinuation, discretion, discussed, distinguish, ELOC, enable, extinguished, facility, feasibility, Food, Forbearance, harbor, Healthcare, high, immunology, improved, Incorporation, increased, IND, infusion, intended, intent, IV, JMML, juvenile, leukemia, line, LOI, Madison, Master, matured, mg, misappropriation, Modification, MTD, myelomonocytic, neurotoxicity, newly, notified, obligated, obtained, offering, ordinary, orphan, par, pediatric, personal, pivotal, poor, positive, preclinical, priority, progressing, prosecution, Put, rare, reached, real, realized, receipt, recommended, reduced, reevaluated, Reform, reimbursed, released, Restated, RPTD, safe, satisfied, secured, settled, settlement, shifted, study, terminated, termination, thereunder, Title, tolerated, trade, translate, unmet, upfront, worth, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HGENQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Cameron Durrant, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Humanigen, Inc. for the quarter ended March 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Humanigen, Inc.

Date: May 3, 2019
	By:	/s/ Cameron Durrant
	Name:	Cameron Durrant
	Title:	Chief Executive Officer
		(Principal Executive Officer)